Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-03-27

FDA Approved: ASENAPINE — Supplemental Application (Sigmapharm Laboratories, LLC)

View source ↗

Summary

FDA approved a supplemental application for asenapine from Sigmapharm Laboratories, allowing a generic version of asenapine to be marketed. The supplemental app…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Asenapine (asenapine)

Snippet

SUPPL AP for ASENAPINE (ASENAPINE)